This Phase 2 study aims to evaluate whether Bruton's tyrosine kinase (BTK) inhibition with remibrutinib can produce a clinically meaningful reduction in inflam…

Papulopustular Rosacea

~Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT07681271

Phase 2

Efficacy and Safety of Topical Clascoterone Cream 1% in Patients With Facial Acneiform Rosacea

To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.

Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea

~Estimated

~$10 – $7,500

Narrows Institute for Biomedical ResearchNCT06952517